Hippo pathway effector YAP inhibition restores the sensitivity of EGFR-TKI in lung adenocarcinoma having primary or acquired EGFR-TKI resistance.
Lee JE, Park HS, Lee D, Yoo G, Kim T, Jeon H, Yeo MK, Lee CS, Moon JY, Jung SS, Kim JO, Kim SY, Park DI, Park YH, Lee JC, Oh IJ, Lim DS, Chung C.
Lee JE, et al. Among authors: yeo mk.
Biochem Biophys Res Commun. 2016 May 20;474(1):154-160. doi: 10.1016/j.bbrc.2016.04.089. Epub 2016 Apr 20.
Biochem Biophys Res Commun. 2016.
PMID: 27105908